These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19356126)

  • 1. Different concepts of drug delivery in disease entities.
    Serafin A; Stańczak A
    Mini Rev Med Chem; 2009 Apr; 9(4):481-97. PubMed ID: 19356126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodrugs and soft drugs.
    Stańczak A; Ferra A
    Pharmacol Rep; 2006; 58(5):599-613. PubMed ID: 17085852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prodrug approaches for CNS delivery.
    Rautio J; Laine K; Gynther M; Savolainen J
    AAPS J; 2008; 10(1):92-102. PubMed ID: 18446509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodrugs in cardiovascular therapy.
    Sandros MG; Sarraf CB; Tabrizian M
    Molecules; 2008 May; 13(5):1156-78. PubMed ID: 18560335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide prodrugs for the treatment of CNS disorders: a perspective for new drugs.
    Chin CM; Chiba DE; Machado MG; Vizioli Ede O; Santos JL
    Curr Med Chem; 2014; 21(23):2599-609. PubMed ID: 24533804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of microparticulate drug delivery systems composed of macromolecular prodrugs.
    Onishi H; Machida Y
    Molecules; 2008 Aug; 13(9):2136-55. PubMed ID: 18830146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
    Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
    Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutual Prodrugs - Codrugs.
    Nudelman A
    Curr Med Chem; 2023; 30(38):4283-4339. PubMed ID: 36503392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prodrugs: design and clinical applications.
    Rautio J; Kumpulainen H; Heimbach T; Oliyai R; Oh D; Järvinen T; Savolainen J
    Nat Rev Drug Discov; 2008 Mar; 7(3):255-70. PubMed ID: 18219308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent updates in utilizing prodrugs in drug delivery (2013-2015).
    Amly W; Karaman R
    Expert Opin Drug Deliv; 2016; 13(4):571-91. PubMed ID: 26785610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current prodrug design for drug discovery.
    Hsieh PW; Hung CF; Fang JY
    Curr Pharm Des; 2009; 15(19):2236-50. PubMed ID: 19601825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodrugs - an efficient way to breach delivery and targeting barriers.
    Huttunen KM; Rautio J
    Curr Top Med Chem; 2011; 11(18):2265-87. PubMed ID: 21671868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azomethine prodrugs of (R)-alpha-methylhistamine, a highly potent and selective histamine H3-receptor agonist.
    Krause M; Stark H; Schunack W
    Curr Med Chem; 2001 Sep; 8(11):1329-40. PubMed ID: 11562269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What should be considered on design of a colon-specific prodrug?
    Jung Y; Kim YM
    Expert Opin Drug Deliv; 2010 Feb; 7(2):245-58. PubMed ID: 20095945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prospects of lipidic prodrugs: an old approach with an emerging future.
    Dahan A; Markovic M; Aponick A; Zimmermann EM; Ben-Shabat S
    Future Med Chem; 2019 Oct; 11(19):2563-2571. PubMed ID: 31633401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prodrugs for transdermal drug delivery - trends and challenges.
    Ita KB
    J Drug Target; 2016 Sep; 24(8):671-8. PubMed ID: 26878159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.
    Shen J; Lu GW; Hughes P
    Pharm Res; 2018 Sep; 35(11):217. PubMed ID: 30255364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodrugs as self-assembled hydrogels: a new paradigm for biomaterials.
    Vemula PK; Wiradharma N; Ankrum JA; Miranda OR; John G; Karp JM
    Curr Opin Biotechnol; 2013 Dec; 24(6):1174-82. PubMed ID: 23465753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The blood-brain barrier: clinical implications for drug delivery to the brain.
    De Boer AG; Breimer DD
    J R Coll Physicians Lond; 1994; 28(6):502-6. PubMed ID: 7884704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.